RCM
EXAS

Raleigh Capital Management’s Exact Sciences EXAS Stock Holding History

Raleigh Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-161
Closed -$11.9K – 1028
2023
Q4 		$11.9K Sell
161
-278
-63% -$18.2K 0.01% 548
2023
Q3 		$29.9K Buy
439
+47
+12% +$3.99K 0.02% 322
2023
Q2 		$36.8K Buy
+392
New +$30.6K 0.02% 282

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raleigh Capital Management's EXAS Position: Q1 2024 in Review

Raleigh Capital Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 161 shares — an estimated $11.9K sold.

Raleigh Capital Management first reported a position in EXAS in Q2 2023 and held it in 3 quarters. The position peaked at $36.8K in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Raleigh Capital Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 161 Exact Sciences shares in Q1 2024, an estimated $11.9K.
  • Raleigh Capital Management first reported a position in Exact Sciences in Q2 2023 and held it in 3 quarters.
  • Raleigh Capital Management's Exact Sciences position peaked at $36.8K in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.